NZ231909A - Transdermal therapeutical system comprising norpseudoephedrine in an adhesive polymeric reservoir layer - Google Patents
Transdermal therapeutical system comprising norpseudoephedrine in an adhesive polymeric reservoir layerInfo
- Publication number
- NZ231909A NZ231909A NZ231909A NZ23190989A NZ231909A NZ 231909 A NZ231909 A NZ 231909A NZ 231909 A NZ231909 A NZ 231909A NZ 23190989 A NZ23190989 A NZ 23190989A NZ 231909 A NZ231909 A NZ 231909A
- Authority
- NZ
- New Zealand
- Prior art keywords
- norpseudoephedrine
- reservoir layer
- adhesive polymeric
- polymeric reservoir
- therapeutical system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a transdermal therapeutic system for applying an active substance to the skin and consisting of a backing layer impermeable to the active substance, a reservoir layer and, if appropriate, a detachable protective layer, the reservoir layer being adhesive and containing 10-90% by weight of polymer material, 0-30% by weight of softener and 0.1-20% by weight of a norpseudoephedrine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3843237A DE3843237A1 (en) | 1988-12-22 | 1988-12-22 | TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ANTIADIPOSITUM AS AN ACTIVE INGREDIENT |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ231909A true NZ231909A (en) | 1991-06-25 |
Family
ID=6369853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ231909A NZ231909A (en) | 1988-12-22 | 1989-12-20 | Transdermal therapeutical system comprising norpseudoephedrine in an adhesive polymeric reservoir layer |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0374725B1 (en) |
JP (1) | JP2602108B2 (en) |
KR (1) | KR950015055B1 (en) |
AT (1) | ATE93147T1 (en) |
AU (1) | AU614208B2 (en) |
CA (1) | CA2006425C (en) |
CS (1) | CS275356B2 (en) |
DD (1) | DD290581A5 (en) |
DE (2) | DE3843237A1 (en) |
DK (1) | DK651089A (en) |
ES (1) | ES2045369T3 (en) |
FI (1) | FI95772C (en) |
HU (1) | HU203280B (en) |
IE (1) | IE63878B1 (en) |
IL (1) | IL92678A (en) |
MY (1) | MY105074A (en) |
NO (1) | NO178784C (en) |
NZ (1) | NZ231909A (en) |
PH (1) | PH25854A (en) |
PL (1) | PL163292B1 (en) |
PT (1) | PT92650B (en) |
YU (1) | YU47075B (en) |
ZA (1) | ZA899879B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3939376C1 (en) * | 1989-11-29 | 1991-05-08 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De | |
DE4342893C2 (en) * | 1993-12-16 | 1999-09-23 | Lohmann Gmbh & Co Kg | Reversible adhesive, residue-free removable pressure sensitive adhesive, process for its production and use as re-adhesive pressure sensitive adhesive articles |
AU2727801A (en) * | 1999-12-16 | 2001-06-25 | Dermatrends, Inc. | Transdermal administration of phenylpropanolamine |
US6602912B2 (en) | 2000-06-30 | 2003-08-05 | Dermatrends, Inc. | Transdermal administration of phenylpropanolamine |
US6673363B2 (en) | 1999-12-16 | 2004-01-06 | Dermatrends, Inc. | Transdermal and topical administration of local anesthetic agents using basic enhancers |
US6719997B2 (en) | 2000-06-30 | 2004-04-13 | Dermatrends, Inc. | Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers |
KR100956865B1 (en) * | 2009-08-10 | 2010-05-11 | 주식회사 라이트론 | Slide pressure packing type linear lighting apparatus |
US20190298661A1 (en) * | 2016-10-31 | 2019-10-03 | The Corporation Of Mercer University | Transdermal Delivery of Phenethylamine Monoamine Releasers |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
JPS57116011A (en) * | 1981-01-08 | 1982-07-19 | Nitto Electric Ind Co Ltd | Pharmaceutical preparation |
JPS60185713A (en) * | 1984-03-05 | 1985-09-21 | Nitto Electric Ind Co Ltd | Percutaneous preparation and its production |
EP0156080B2 (en) * | 1984-03-05 | 1993-10-20 | Nitto Denko Corporation | Percutaneous absorption type adhesive pharmaceutical preparation |
US4692462A (en) * | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
DE3629304A1 (en) * | 1986-08-28 | 1988-03-24 | Lohmann Gmbh & Co Kg | TRANSDERMAL THERAPEUTIC SYSTEM, ITS USE AND METHOD FOR THE PRODUCTION THEREOF |
DE3743945A1 (en) * | 1987-09-01 | 1989-03-09 | Lohmann Gmbh & Co Kg | DEVICE FOR DELIVERING SUBSTANCES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
-
1988
- 1988-12-22 DE DE3843237A patent/DE3843237A1/en active Granted
-
1989
- 1989-12-13 IL IL9267889A patent/IL92678A/en not_active IP Right Cessation
- 1989-12-14 MY MYPI89001760A patent/MY105074A/en unknown
- 1989-12-14 AT AT89123091T patent/ATE93147T1/en not_active IP Right Cessation
- 1989-12-14 DE DE8989123091T patent/DE58905320D1/en not_active Expired - Fee Related
- 1989-12-14 ES ES89123091T patent/ES2045369T3/en not_active Expired - Lifetime
- 1989-12-14 EP EP89123091A patent/EP0374725B1/en not_active Expired - Lifetime
- 1989-12-18 AU AU46843/89A patent/AU614208B2/en not_active Ceased
- 1989-12-19 FI FI896097A patent/FI95772C/en not_active IP Right Cessation
- 1989-12-19 IE IE407789A patent/IE63878B1/en not_active IP Right Cessation
- 1989-12-19 CS CS897193A patent/CS275356B2/en unknown
- 1989-12-19 YU YU240589A patent/YU47075B/en unknown
- 1989-12-20 NZ NZ231909A patent/NZ231909A/en unknown
- 1989-12-20 DK DK651089A patent/DK651089A/en not_active Application Discontinuation
- 1989-12-20 PH PH39752A patent/PH25854A/en unknown
- 1989-12-21 CA CA002006425A patent/CA2006425C/en not_active Expired - Fee Related
- 1989-12-21 HU HU896721A patent/HU203280B/en not_active IP Right Cessation
- 1989-12-21 DD DD89336084A patent/DD290581A5/en not_active IP Right Cessation
- 1989-12-21 ZA ZA899879A patent/ZA899879B/en unknown
- 1989-12-21 PT PT92650A patent/PT92650B/en not_active IP Right Cessation
- 1989-12-21 NO NO895173A patent/NO178784C/en unknown
- 1989-12-22 KR KR1019890019229A patent/KR950015055B1/en not_active IP Right Cessation
- 1989-12-22 JP JP1331442A patent/JP2602108B2/en not_active Expired - Lifetime
- 1989-12-22 PL PL89282948A patent/PL163292B1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY105347A (en) | Transdermal therapeutic system comprising as active component buprenorphine | |
PT92652A (en) | METHOD FOR PREPARING A TRANSDERMM THERAPEUTIC SYSTEM CONTAINING PHYSOSTIGMINE AS ACTIVE INGREDIENT | |
NZ231908A (en) | Transdermal therapeutical system comprising physostigmine in a polymer-based reservoir layer | |
NZ231909A (en) | Transdermal therapeutical system comprising norpseudoephedrine in an adhesive polymeric reservoir layer |